Bhatt DL, et al. “Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events”. The New England Journal of Medicine. 2013. 368(14):1303-1313.
Category: Cardiology
CAST Trial. Mortality and morbidity in patients receiving Encainide, Flecainide, or Placebo
Table of Contents Clinical Literature Summary Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial Authors (Top 5): D.…
2014 ESC Guidelines on the Diagnosis and Treatment of Aortic Diseases
Full Text PubMed 2014 ESC Guidelines on Aortic Diseases Introduction to Aortic Disease Guidelines Citation: Erbel R, Aboyans V, Boileau C, et al. 2014 ESC…
2014 ESC Guidelines on the Diagnosis and Treatment of Aortic Diseases
EAU Guidelines on Urolithiasis (Limited Text Update March 2022) Authors: A. Skolarikos (Chair), A. Neisius, A. Petřík, B. Somani, K. Thomas, G. Gambaro Guidelines Associates:…
Management of Hypertensive Emergency
Introduction Hypertensive emergency is characterized by systolic blood pressure (SBP) > 180 mmHg or diastolic blood pressure (DBP) > 120 mmHg with evidence of target…
Fibrinolytics for STEMI
Introduction Percutaneous coronary intervention (PCI) is the preferred reperfusion strategy during a cardiac arrest; thrombolytic therapy is an option without PCI capability, followed by transfer…
Procainamide for Wide Complex Tachycardia
Introduction Ventricular tachycardia (VT) is an uncommon but dangerous medical condition, with an extremely variable clinical presentation. Intravenous procainamide is guideline recommended and is the…
Push Dose Vasopressors
Patient Case The team gets a call that there is a 75 year old male that triggered a sepsis alert in route with EMS…